SVB Leerink partners with innovative healthcare services companies that strive to transform and improve the healthcare industry. SVB Leerink’s dedicated healthcare services team helps our clients achieve their strategic and financial goals.Contact Us
SVB Leerink’s healthcare services team has significant M&A and capital markets experience which enables us to bring exceptional knowledge and insight to our clients. We offer these comprehensive advisory capabilities through healthcare services sector specialists and M&A bankers that bring expertise across subsectors, geographies, and deal structures.
Related Banking Team
Global Co-Head of Healthcare Investment Banking
Barry Blake is the Global Co-Head of Healthcare Investment Banking at SVB Leerink. In this role, Mr. Blake co-leads the firm’s healthcare investment banking strategy and initiatives, with a focus on Healthcare Services & Technology. With 25 years of experience, Mr. Blake has built extensive relationships and has proven expertise in healthcare services, leveraged finance and with financial sponsors.
Mr. Blake joined the firm in 2021 from Guggenheim Securities where he was a Senior Managing Director focused on advising healthcare services companies. While at Guggenheim, Mr. Blake worked on many transactions including, but not limited to, the $10B sale of Envision to KKR; the $4B sale of Kindred Healthcare to a consortium comprised of TPG, Welsh Carson and Humana; the $2.4B sale of American Medical Response to KKR and the $1B sale of Almost Family to LHC Group. Prior to this, Mr. Blake was the Head of Global Healthcare Mergers and Acquisitions for Citigroup and worked in the M&A and Healthcare groups at JP Morgan and Lehman Brothers.
Mr. Blake earned his Bachelor of Arts in Economics from Hendrix College, and his Masters of Business Administration from the Amos Tuck School at Dartmouth College.
He serves as a member of the Board of Trustees for each of The Hopkins School in New Haven, CT and Hendrix College in Conway, AR.
Managing Director, Healthcare Services
Jeff Danesis is a Managing Director of Investment Banking at SVB Leerink and oversees the firm’s Physician Services Investment Banking franchise.
Mr. Danesis’ career spans over 12 years of healthcare investment banking expertise and over 30 closed transactions. He has extensive deal experience in physician-centric businesses with a particular emphasis on physician practice management and outpatient provider models. Notable recent transactions include advising Austin Radiological Association on its partnership with Radiology Partners; the recapitalization of Dermatologists of Central States by Sheridan Capital Partners; the recapitalization of Charlotte Radiology by Welsh, Carson, Anderson & Stowe to form U.S. Radiology Specialists; the sale of Midwest Center for Dermatology and Cosmetic Surgery to an undisclosed buyer; and the sale of Cleveland HeartLab by Quest Diagnostics.
Prior to joining the firm in 2014, Mr. Danesis was a Director in the Healthcare Group at Lazard and a member of the Healthcare Investment Banking Group at Wachovia Securities.
Mr. Danesis earned his M.B.A. from the University of Chicago and his B.A. from Northwestern University.
Related Research Team
Managing Director, Healthcare Technology and Distribution
Stephanie Davis is a Senior Research Analyst at SVB Leerink covering Healthcare Technology and Distribution. She has over a decade of experience covering the Healthcare IT and IT Services sectors and leads the firm’s digital health research efforts.
Prior to joining the firm, Ms. Davis worked at Citibank where she led coverage for the Healthcare IT sector, including the electronic health record companies, payer-facing and provider-facing IT players. Before Citi, Ms. Davis was an Equity Research Analyst at J.P. Morgan and, earlier in her career, was an Investment Banking Analyst at Sonenshine Partners.
In 2019, Ms. Davis was recognized as a Runner-Up for Health Care Technology and Distribution on Institutional Investor’s All America Research Team and was included in Business Insider’s “Rising Stars of Equity Research” in 2017.
Ms. Davis earned a B.A. in Economics and Mathematics from Columbia University and is a CFA charterholder.